Form 4: Myomo Inc. Chief Medical Officer Receives Stock Grant

Harry Kovelman, Chief Medical Officer of Myomo, Inc., was granted 53,000 shares of common stock in the form of Restricted Stock Units.

Summary

• Harry Kovelman, the Chief Medical Officer of Myomo, Inc., received a grant of 53,000 Restricted Stock Units (RSUs) on June 5, 2024.
• These RSUs represent a contingent right to receive one share of Myomo's common stock per unit.
• The RSUs will vest in annual installments over three years, starting on June 5, 2025.
• Following this transaction, Kovelman beneficially owns 150,888 shares of Myomo common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral to slightly positive event.

Positives

• The grant of RSUs aligns the Chief Medical Officer's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance, but the RSU grant suggests an expectation of continued service from the Chief Medical Officer.

Industry Context

Stock grants are a common form of executive compensation in the biotechnology and medical device industries, aligning management's interests with shareholder value creation.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign, aligning management's interests with long-term company performance.
• Employees may see the grant as a sign of confidence in the company's future.

Key Dates